Roche names Foundation Medicine CEO Malarek to lead North America diagnostics unit

  • Roche appointed Dan Malarek president and CEO of Roche Diagnostics North America, effective Aug. 1, 2026.
  • Malarek is CEO of Foundation Medicine, a Roche affiliate; he joined Roche in 2007, holding diagnostics marketing, GM, and global roles.
  • He replaces Brad Moore, set to retire at end-July following nearly 10 years at Roche.
  • Antonio Vergara named chief commercial officer of Roche Diagnostics U.S. in a new role from Aug. 1, reporting to Malarek.
  • Foundation Medicine COO Vera Grossmann becomes interim CEO from Aug. 1 while a permanent successor is sought.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Roche Holding AG published the original content used to generate this news brief via PR Newswire (Ref. ID: 202607200820PR_NEWS_USPR_____SF07245) on July 20, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.